As of May 26
| +0.40 / +1.59%|
The 7 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 29.00, with a high estimate of 31.00 and a low estimate of 19.00. The median estimate represents a +13.50% increase from the last price of 25.55.
The current consensus among 7 polled investment analysts is to Buy stock in PharMerica Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.